Criteria to be used to activate a spontaneous breathing trial include the patient (a) being arousable; (b) being hemodynamically stable (without vasopressor agents); (c) having no new potentially serious conditions; (d) having low ventilatory and end-expiratory pressure requirements; and (e) having low FIO2 requirements that can be met safely when oxygen is delivered with a face mask or a nasal cannula.